Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Revolution Medicines, Inc.(RVMD) | 580,678 | 562,630 | -18,048 | $56.47M | $105.37M | 20.09% | +$48.90M |
| Spdr S&p Biotech EtfETF ST STR SP BIOT | 318,505 | 196,505 | -122,000 | $40.68M | $31.10M | 5.93% | -$9.59M |
| COMPASS Pathways plcADS(CMPS) | 2,418,882 | 2,011,952 | -406,930 | $13.38M | $28.47M | 5.43% | +$15.09M |
| Stereotaxis, Inc.(STXS) | 13,680,554 | 13,680,554 | 0 | $25.17M | $23.53M | 4.49% | -$1.64M |
| Nektar Therapeutics(NKTR) | 165,178 | 318,380 | +153,202 | $11.88M | $22.23M | 4.24% | +$10.34M |
| Denali Therapeutics Inc.(DNLI) | 318,500 | 739,014 | +420,514 | $6.12M | $19.01M | 3.62% | +$12.89M |
| IDEAYA Biosciences, Inc.(IDYA) | 476,740 | 497,240 | +20,500 | $15.88M | $18.53M | 3.53% | +$2.65M |
| AtriCure, Inc.(ATRC) | 597,431 | 597,431 | 0 | $17.04M | $16.72M | 3.19% | -$328.6K |
| Xenon Pharmaceuticals Inc.(XENE) | 250,772 | 250,772 | 0 | $14.58M | $15.14M | 2.89% | +$554.2K |
| Cytokinetics, Incorporated(CYTK) | 217,497 | 171,998 | -45,499 | $14.34M | $14.65M | 2.79% | +$317.3K |
| Arcus Biosciences, Inc.(RCUS) | 443,829 | 441,829 | -2,000 | $9.59M | $13.62M | 2.60% | +$4.03M |
| Ascendis Pharma A/S(ASND) | 0 | 48,469 | +48,469 | $0 | $12.93M | 2.47% | +$12.93M |
| Neurocrine Biosciences, Inc.(NBIX) | 70,615 | 57,769 | -12,846 | $9.30M | $9.74M | 1.86% | +$433.3K |
| Axogen, Inc.(AXGN) | 249,960 | 208,960 | -41,000 | $8.28M | $9.65M | 1.84% | +$1.37M |
| Insulet Corporation(PODD) | 10,870 | 61,870 | +51,000 | $2.28M | $9.42M | 1.80% | +$7.14M |
| Edgewise Therapeutics, Inc.(EWTX) | 112,236 | 226,819 | +114,583 | $3.54M | $9.22M | 1.76% | +$5.68M |
| Bicara Therapeutics Inc | 421,733 | 284,955 | -136,778 | $8.39M | $8.46M | 1.61% | +$72.0K |
| Ishares Nasdaq Biotech IndxETF | 62,095 | 42,595 | -19,500 | $10.48M | $8.10M | 1.54% | -$2.38M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 217,355 | 335,255 | +117,900 | $5.08M | $7.33M | 1.40% | +$2.25M |
| MapLight Therapeutics, Inc.(MPLT) | 171,006 | 171,006 | 0 | $3.48M | $6.13M | 1.17% | +$2.65M |
| Larimar Therapeutics, Inc.(LRMR) | 2,029,164 | 2,008,164 | -21,000 | $9.13M | $6.12M | 1.17% | -$3.01M |
| Century Therapeutics, Inc.(IPSC) | 2,434,353 | 2,400,458 | -33,895 | $5.50M | $5.88M | 1.12% | +$379.5K |
| DexCom, Inc.(DXCM) | 86,279 | 86,279 | 0 | $5.42M | $5.81M | 1.11% | +$392.6K |
| Immunovant, Inc.(IMVT) | 150,524 | 149,524 | -1,000 | $3.74M | $5.76M | 1.10% | +$2.02M |
| Inogen, Inc.(INGN) | 845,179 | 845,179 | 0 | $5.22M | $5.45M | 1.04% | +$228.2K |
| Tandem Diabetes Care, Inc.(TNDM) | 355,208 | 355,208 | 0 | $6.81M | $5.36M | 1.02% | -$1.45M |
| Alkermes plcSHS(ALKS) | 139,482 | 101,266 | -38,216 | $4.93M | $5.31M | 1.01% | +$373.7K |
| Stoke Therapeutics, Inc.(STOK) | 130,875 | 130,875 | 0 | $4.26M | $4.28M | 0.82% | +$20.9K |
| Allogene Therapeutics Inc | 1,370,118 | 2,000,000 | +629,882 | $3.34M | $4.16M | 0.79% | +$816.9K |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 430,248 | 400,248 | -30,000 | $4.10M | $4.00M | 0.76% | -$93.5K |
| Lakefront Biotherapeutics NVADR(LKFT) | 130,175 | 130,175 | 0 | $3.91M | $3.90M | 0.74% | -$2.6K |
| OrthoPediatrics Corp.(KIDS) | 95,659 | 189,130 | +93,471 | $1.52M | $3.62M | 0.69% | +$2.10M |
| Cybin D/B/A Helus Pharma(HELP) | 498,361 | 514,061 | +15,700 | $2.39M | $3.40M | 0.65% | +$1.01M |
| Rapport Therapeutics, Inc.(RAPP) | 75,000 | 75,000 | 0 | $2.35M | $3.13M | 0.60% | +$778.5K |
| Kymera Therapeutics, Inc.(KYMR) | 0 | 27,000 | +27,000 | $0 | $3.10M | 0.59% | +$3.10M |
| Proqr Therapeutics NvSHS EURO SHS EURO | 1,567,561 | 1,530,361 | -37,200 | $2.54M | $2.85M | 0.54% | +$307.0K |
| Neurogene Inc.(NGNE) | 56,635 | 89,032 | +32,397 | $1.14M | $2.80M | 0.53% | +$1.66M |
| Adlai Nortye Group Ltd.ADS(ANL) | 0 | 239,553 | +239,553 | $0 | $2.75M | 0.53% | +$2.75M |
| PROCEPT BioRobotics Corporation(PRCT) | 120,000 | 120,000 | 0 | $3.00M | $2.71M | 0.52% | -$291.6K |
| Aquestive Therapeutics Inc | 368,415 | 645,915 | +277,500 | $1.53M | $2.69M | 0.51% | +$1.16M |
| Celldex Therapeutics, Inc.(CLDX) | 68,518 | 68,518 | 0 | $2.17M | $2.55M | 0.49% | +$376.2K |
| Structure Therapeutics IncADS | 46,500 | 46,500 | 0 | $2.24M | $2.50M | 0.48% | +$254.4K |
| Align Technology Inc | 15,000 | 14,000 | -1,000 | $2.57M | $2.36M | 0.45% | -$210.2K |
| Viking Therapeutics, Inc.(VKTX) | 59,516 | 59,516 | 0 | $1.94M | $2.32M | 0.44% | +$385.1K |
| NervGen Pharma Corp.(NGEN) | 0 | 1,050,000 | +1,050,000 | $0 | $2.16M | 0.41% | +$2.16M |
| Biohaven Ltd.(BHVN) | 845,735 | 137,593 | -708,142 | $7.15M | $2.05M | 0.39% | -$5.11M |
| Maze Therapeutics, Inc.(MAZE) | 35,000 | 65,000 | +30,000 | $1.04M | $1.94M | 0.37% | +$894.9K |
| Alector Inc | 908,351 | 908,351 | 0 | $1.95M | $1.83M | 0.35% | -$127.2K |
| Lexeo Therapeutics, Inc.(LXEO) | 377,059 | 377,059 | 0 | $2.16M | $1.76M | 0.33% | -$409.1K |
| Profound Medical Corp.(PROF) | 263,005 | 260,360 | -2,645 | $1.70M | $1.73M | 0.33% | +$27.1K |
| Atrium Therapeutics, Inc.(RNA) | 0 | 128,000 | +128,000 | $0 | $1.72M | 0.33% | +$1.72M |
| Annexon, Inc.(ANNX) | 117,812 | 297,812 | +180,000 | $652.7K | $1.70M | 0.32% | +$1.05M |
| CytomX Therapeutics, Inc.(CTMX) | 230,000 | 438,407 | +208,407 | $1.08M | $1.64M | 0.31% | +$563.0K |
| Ultragenyx Pharmaceutical Inc.(RARE) | 61,100 | 47,100 | -14,000 | $1.28M | $1.57M | 0.30% | +$292.6K |
| Eupraxia Pharmaceuticals Inc.(EPRX) | 0 | 225,600 | +225,600 | $0 | $1.49M | 0.28% | +$1.49M |
| Design Therapeutics, Inc.(DSGN) | 0 | 102,600 | +102,600 | $0 | $1.48M | 0.28% | +$1.48M |
| Fate Therapeutics, Inc.(FATE) | 550,000 | 525,000 | -25,000 | $660.0K | $1.42M | 0.27% | +$757.5K |
| MediWound Ltd.SHS NEW(MDWD) | 94,405 | 94,405 | 0 | $1.52M | $1.39M | 0.26% | -$133.1K |
| Kura Oncology, Inc.(KURA) | 235,868 | 120,568 | -115,300 | $1.92M | $1.32M | 0.25% | -$595.0K |
| ARS Pharmaceuticals, Inc.(SPRY) | 139,285 | 164,285 | +25,000 | $1.12M | $1.32M | 0.25% | +$197.5K |
| Mineralys Therapeutics, Inc.(MLYS) | 38,490 | 44,490 | +6,000 | $1.04M | $1.20M | 0.23% | +$157.6K |
| Immatics N.V.SHS(IMTX) | 225,860 | 116,960 | -108,900 | $2.22M | $1.18M | 0.23% | -$1.04M |
| TELA Bio, Inc.(TELA) | 1,441,029 | 1,441,029 | 0 | $893.4K | $1.08M | 0.21% | +$187.3K |
| PolyPid Ltd.(PYPD) | 207,900 | 207,900 | 0 | $910.6K | $1.06M | 0.20% | +$145.5K |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 0 | 107,773 | +107,773 | $0 | $1.01M | 0.19% | +$1.01M |
| Inspire Medical Systems, Inc.(INSP) | 18,200 | 18,200 | 0 | $938.8K | $811.9K | 0.15% | -$126.9K |
| Adicet Bio Inc | 93,812 | 93,812 | 0 | $638.9K | $810.5K | 0.15% | +$171.7K |
| Seaport Therapeutics Inc | 0 | 32,400 | +32,400 | $0 | $703.7K | 0.13% | +$703.7K |
| MBX Biosciences, Inc.(MBX) | 175,465 | 11,809 | -163,656 | $5.24M | $651.9K | 0.12% | -$4.59M |
| BioNTech SEADS(BNTX) | 7,000 | 7,000 | 0 | $622.2K | $651.4K | 0.12% | +$29.2K |
| Artiva Biotherapeutics, Inc.(ARTV) | 0 | 67,101 | +67,101 | $0 | $650.9K | 0.12% | +$650.9K |
| Pliant Therapeutics, Inc.(PLRX) | 487,000 | 487,000 | 0 | $613.6K | $555.2K | 0.11% | -$58.4K |
| Scynexis Inc | 0 | 135,868 | +135,868 | $0 | $553.0K | 0.11% | +$553.0K |
| Editas Medicine, Inc.(EDIT) | 0 | 170,470 | +170,470 | $0 | $552.3K | 0.11% | +$552.3K |
| Orchestra BioMed Holdings, Inc.(OBIO) | 126,841 | 126,841 | 0 | $539.1K | $547.3K | 0.10% | +$8.2K |
| Foghorn Therapeutics Inc.(FHTX) | 111,859 | 111,859 | 0 | $534.7K | $545.9K | 0.10% | +$11.2K |
| Accuray Inc | 1,680,508 | 1,680,508 | 0 | $652.2K | $433.2K | 0.08% | -$219.0K |
| Q32 Bio Inc.(QTTB) | 0 | 32,896 | +32,896 | $0 | $419.1K | 0.08% | +$419.1K |
| Nuvectis Pharma, Inc.(NVCT) | 0 | 20,000 | +20,000 | $0 | $367.8K | 0.07% | +$367.8K |
| Compugen Ltd.(CGEN) | 257,783 | 168,232 | -89,551 | $549.1K | $360.0K | 0.07% | -$189.1K |
| iBio, Inc.(IBIO) | 193,638 | 170,053 | -23,585 | $367.9K | $297.6K | 0.06% | -$70.3K |
| Autolus Therapeutics plcADS(AUTL) | 179,316 | 179,316 | 0 | $247.5K | $286.9K | 0.05% | +$39.5K |
| Bicycle Therapeutics PlcADS | 64,492 | 64,492 | 0 | $299.2K | $273.4K | 0.05% | -$25.8K |
| Tenaya Therapeutics, Inc.(TNYA) | 0 | 300,000 | +300,000 | $0 | $221.7K | 0.04% | +$221.7K |
| Verrica Pharmaceuticals Inc.(VRCA) | 153,712 | 23,750 | -129,962 | $813.1K | $145.3K | 0.03% | -$667.8K |
| enGene Therapeutics Inc.(ENGN) | 0 | 74,650 | +74,650 | $0 | $129.1K | 0.02% | +$129.1K |
| Kardigan Inc | 0 | 5,000 | +5,000 | $0 | $119.3K | 0.02% | +$119.3K |
| ADC Therapeutics SASHS(ADCT) | 72,081 | 77,081 | +5,000 | $270.3K | $82.5K | 0.02% | -$187.8K |
| Ascendis Pharma A/SNOTE 2 250 4 0(ASND) | 0 | 0 | 0 | $5.92M | $0 | — | -$5.92M |
| Ascendis Pharma A/SADR(ASND) | 23,177 | 0 | -23,177 | $5.30M | $0 | — | -$5.30M |
| Day One Biopharmaceuticals I COM | 978,463 | 0 | -978,463 | $20.98M | $0 | — | -$20.98M |
| Engene Holdings Inc COM | 187,353 | 0 | -187,353 | $1.28M | $0 | — | -$1.28M |
| Fulcrum Therapeutics, Inc.(FULC) | 205,000 | 0 | -205,000 | $1.57M | $0 | — | -$1.57M |
| Kalvista Pharmaceuticals Inc | 267,402 | 0 | -267,402 | $5.38M | $0 | — | -$5.38M |
| Karyopharm Therapeutics Inc.(KPTI) | 45,800 | 0 | -45,800 | $255.1K | $0 | — | -$255.1K |
| Neumora Therapeutics, Inc.(NMRA) | 70,000 | 0 | -70,000 | $136.5K | $0 | — | -$136.5K |
| Newamsterdam Pharma Co ORDINARY SHARES | 20,000 | 0 | -20,000 | $640.2K | $0 | — | -$640.2K |
| ORIC Pharmaceuticals, Inc.(ORIC) | 98,724 | 0 | -98,724 | $945.5K | $0 | — | -$945.5K |
| SCYNEXIS, Inc.(SCYX) | 1,086,956 | 0 | -1,086,956 | $996.6K | $0 | — | -$996.6K |
| Zenas BioPharma, Inc.(ZBIO) | 42,500 | 0 | -42,500 | $830.9K | $0 | — | -$830.9K |